(RECS) Columbia Trust I - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US19761L7064 • Large Blend

RECS: U.S. Large, Mid-Cap, Blend, ETF

The Columbia Research Enhanced Core ETF (RECS) is designed to track the performance of a rules-based index that selects a subset of companies from the Russell 1000® Index. The fund invests at least 80% of its assets in the securities of this index, which is constructed to represent U.S. large- and mid-cap companies across both growth and value segments. The index typically holds between 325-400 constituents, though this number can vary as it has no fixed limit on the number of holdings. This flexible approach allows the index to adapt to market conditions while maintaining its core objective of reflecting the performance of U.S. large- and mid-cap equities.

As of the latest data, RECS has an average 20-day volume of 748,700 shares, indicating moderate trading activity. The ETF is currently priced at $32.75, slightly above its 20-day SMA of $31.58 but below its 50-day SMA of $33.12 and 200-day SMA of $33.79. This suggests that the fund is currently in a consolidation phase, with short-term momentum slightly weakening compared to its longer-term trend. The Average True Range (ATR) of 0.93 reflects relatively low volatility, making it a stable choice for investors seeking exposure to large-cap U.S. equities with reduced price fluctuations.

With assets under management (AUM) of $2.219 billion, RECS is a mid-sized ETF, offering a balance between liquidity and diversification. Its focus on a rules-based index ensures a systematic approach to portfolio construction, reducing reliance on discretionary decisions. This structure appeals to investors seeking a low-maintenance, passive investment strategy that closely tracks the performance of U.S. large- and mid-cap companies.

Based on the provided technical and fundamental data: - Short-Term (Next 3 Months): RECS is expected to remain range-bound between $31.50 and $34.00, driven by its current position relative to its moving averages. The 50-day SMA of $33.12 and 200-day SMA of $33.79 will likely act as resistance levels, while the 20-day SMA of $31.58 may provide support. - Volatility Outlook: With an ATR of 0.93, daily price fluctuations are expected to remain subdued, averaging less than 3% deviation from the mean. - Fundamental Strength: The AUM of $2.219 billion indicates a stable investor base, suggesting continued interest in the funds low-volatility, large-cap exposure. - Potential Upside: If the broader market gains momentum, RECS could break above its 200-day SMA and test the $35.00 level. Conversely, a market downturn could push the ETF toward $30.00, though its low ATR suggests limited downside risk.

Additional Sources for RECS ETF

RECS ETF Overview

Market Cap in USD 2,219m
Category Large Blend
TER 0.15%
IPO / Inception 2019-09-25

RECS ETF Ratings

Growth Rating 78.4
Fundamental -
Dividend Rating 39.8
Rel. Strength -0.56
Analysts -
Fair Price Momentum 31.35 USD
Fair Price DCF -

RECS Dividends

Dividend Yield 12m 1.14%
Yield on Cost 5y 2.52%
Annual Growth 5y 7.12%
Payout Consistency 69.6%

RECS Growth Ratios

Growth Correlation 3m -87.9%
Growth Correlation 12m 54.3%
Growth Correlation 5y 87.7%
CAGR 5y 17.17%
CAGR/Max DD 5y 0.78
Sharpe Ratio 12m 1.38
Alpha -0.25
Beta 0.956
Volatility 25.14%
Current Volume 3076.1k
Average Volume 20d 748.7k
What is the price of RECS stocks?
As of May 02, 2025, the stock is trading at USD 33.12 with a total of 3,076,105 shares traded.
Over the past week, the price has changed by +2.44%, over one month by -0.60%, over three months by -6.07% and over the past year by +12.40%.
Is Columbia Trust I a good stock to buy?
Yes. Based on ValueRay Analyses, Columbia Trust I (NYSE ARCA:RECS) is currently (May 2025) a good stock to buy. It has a ValueRay Growth Rating of 78.35 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of RECS as of May 2025 is 31.35. This means that RECS is currently overvalued and has a potential downside of -5.34%.
Is RECS a buy, sell or hold?
Columbia Trust I has no consensus analysts rating.
What are the forecast for RECS stock price target?
According to ValueRays Forecast Model, RECS Columbia Trust I will be worth about 36.2 in May 2026. The stock is currently trading at 33.12. This means that the stock has a potential upside of +9.36%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 36.2 9.4%